So Gilead gets hold put on in March this year by t

So Gilead gets hold put on in March this year by the FDA, just like us, they put a clinical hold on a trial of lenacapavir, but this was lifted in May and, in July, the FDA accepted the New Drug Application (NDA) resubmission for investigational lenacapavir. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of December 27, 2022. Additional regulatory filings and decisions by regulatory authorities are anticipated to continue throughout 2022.

So Gilead gets special treatment to go first on HIV. We NEED to partner with BP now.